Apart from targeting other genes involved in TDP-43 proteinopathies and treating with extracts from patient post-mortem material, there are other paradigms known to lead to TDP-43 nuclear exit by affecting neuronal functions, including axotomies or traumatic brain injury. Here, TARDBP is linked to proteostasis deficiencies.